Patients missing out on millions in 60DD savings, medicinal cannabis sales plunge almost 30%, anti-amyloids unlikely to have meaningful clinical benefit, and more
Click here to download Pharmacy Daily for Thursday 16th April 2026
PARTNER SITES
Other recent headlines
-
Patients missing out on millions in savings
Thursday | Apr 16 2026THE government’s 60-day dispensing policy, designed to cut the cost of medicines for millions of Australians, is not living up to its potential because GPs and pharmacists have been slow to adopt it, new research has found.
-
Med cannabis sales plunge
Thursday | Apr 16 2026MEDICINAL cannabis sales in Australia have fallen sharply for the first time in nearly a decade, with experts from Penington Institute attributing the drop to a regulatory crackdown on high-volume prescribers and clinics.
-
Death knell for anti-amyloids?
Thursday | Apr 16 2026ANTI-AMYLOID drugs for Alzheimer’s disease are unlikely to have any clinically meaningful benefits, but may increase the risk of bleeding and swelling in the brain, according to a new Cochrane review published today.
to top